IMGN.nasdaq
An experimental breast cancer drug from Genentech and ImmunoGen(IMGN Quote) continues to demonstrate an impressive ability to shrink tumors even in patients with advanced disease, although one new safety concern has emerged.
Opinion & investing ideas
Aucun commentaire:
Enregistrer un commentaire